Local Anesthetics

Electron-donating groups = more potency. Look at the Procaine structure above. The –NH₂ at the para position (or ortho, or both) donates electrons into the aromatic ring. This creates a resonance effect with the carbonyl oxygen of the ester linker → the electron cloud around the oxygen increases → higher affinity for the receptor. This is why procaine is far more potent than its unsubstituted analogue (meprylcaine).

Types of electron-donating groups. Several groups work at the para/ortho position: amino (procaine, chloroprocaine), alkylamino (tetracaine — look at the –NH-butyl in the Tetracaine structure), and alkoxy (proparacaine). All enhance potency through the same resonance mechanism.

Electron-withdrawing groups = bad. Adding substituents like –NO₂, –CN, halogens, or –CO₂Et to the aromatic ring reduces local anesthetic activity and shortens duration. These groups pull electrons away, destroying the beneficial resonance with the carbonyl.

The amine can be optional (sort of). Look at the Benzocaine structure — there's no hydrophilic amine group at all, yet benzocaine is a potent local anesthetic. However, the lack of an ionizable group means very poor water solubility, so it can only be used topically.

Amide = more stable than ester. Compare the Lidocaine structure with Procaine. The only structural difference in the linker: procaine has an ester (–COO–), lidocaine has an amide (–NHCO–). Esters and amides are bioisosteres — similar size, shape, and electronic structure, so they bind similarly. But amides are far more resistant to hydrolysis → longer half-life, longer duration of action.

Steric shield from ortho-substituents. In the Lidocaine structure, find the two methyl groups (–CH₃) at both ortho positions of the aromatic ring, flanking the amide linker. These bulky groups create a steric block that physically hinders enzymes from accessing and hydrolyzing the amide bond → even longer duration of action.

Esters → PABA allergy. Ester-type anesthetics (like procaine) get metabolized into PABA (para-aminobenzoic acid). PABA is responsible for the higher incidence of allergic reactions with ester anesthetics. PABA also inhibits sulfonamide antibiotics. Amide anesthetics do not produce PABA, so they have fewer allergy issues.

What the linker does. The linker connects the lipophilic aromatic ring to the hydrophilic amine. It's typically an ester or amide group plus a short hydrocarbon chain. The nature of this linker determines: stability, duration of action, and relative toxicity of the drug.

Longer chain = more of everything. As you increase the number of carbon atoms in the linker chain: lipophilicity ↑, protein binding ↑, duration of action ↑, AND toxicity ↑. There's a sweet spot — too short and the drug is too hydrophilic (poor tissue penetration); too long and toxicity becomes unacceptable.

Ester vs Amide: bioisosteres with different fates. Esters and amides are bioisosteres (same size, shape, electronic properties), so they bind to the Na⁺ channel similarly. But they differ crucially in metabolism: esters are rapidly hydrolyzed by plasma esterases (short t½), while amides are metabolized more slowly by liver enzymes (longer t½).

Tertiary amines are the sweet spot. Most local anesthetics end with a tertiary amine (pKa 7.5–9.5). Why tertiary? Primary amines are too basic and irritating to tissues. Quaternary amines carry a permanent positive charge and cannot penetrate cell membranes. Tertiary amines strike the perfect balance.

pKa determines the ionized:non-ionized ratio. At physiological pH (7.4), the tertiary amine is mostly ionized. The ionized form blocks the Na⁺ channel from the cytoplasmic side. But the drug must first cross the membrane in its non-ionized form. Lower pKa = more non-ionized form = faster onset.

Higher lipid solubility + lower pKa = ideal profile. Local anesthetics with higher lipid solubility (penetrate tissues better) and lower pKa values (more drug in non-ionized form at pH 7.4) tend to show more rapid onset and lower toxicity.

The exception: Benzocaine. As noted earlier, Benzocaine has no amine whatsoever, yet is a potent local anesthetic. But without the ionizable group, it has very poor water solubility — limiting it to topical use only. This proves the amine is primarily needed for formulation and delivery, not for receptor binding itself.